Overview

Use of Xtampza ER to Overcome Difficulties in Swallowing Opioid Pills

Status:
Terminated

Trial end date:
2019-10-31

Target enrollment:

Participant gender:

Summary

This study will examine how the use of Xtampza ER, an opioid analgesic packaged in openable microsphere-containing capsules, affects swallowing satisfaction, pain, and physical and mental health outcomes in chronic pain patients.

Phase:

Phase 4

Details

Lead Sponsor:

Ajay Wasan, MD, Msc

Collaborator:

Collegium Pharmaceutical, Inc.

Treatments:

Analgesics, Opioid
Oxycodone